264 related articles for article (PubMed ID: 2013809)
1. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
Kuwabara H; Gjedde A
J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
[TBL] [Abstract][Full Text] [Related]
2. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
Kuwabara H; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
[TBL] [Abstract][Full Text] [Related]
3. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
4. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
5. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
Dhawan V; Moeller JR; Strother SC; Evans AC; Rottenberg DA
J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
[TBL] [Abstract][Full Text] [Related]
6. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.
Miyazawa H; Osmont A; Petit-Taboué MC; Tillet I; Travère JM; Young AR; Barré L; MacKenzie ET; Baron JC
J Neurosci Methods; 1993 Dec; 50(3):263-72. PubMed ID: 8152238
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver.
Choi Y; Hawkins RA; Huang SC; Brunken RC; Hoh CK; Messa C; Nitzsche EU; Phelps ME; Schelbert HR
J Nucl Med; 1994 May; 35(5):818-23. PubMed ID: 8176464
[TBL] [Abstract][Full Text] [Related]
8. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
9. Metabolic brain imaging. Direct regional measurement of transfer coefficients and lumped constant.
Gjedde A; Kuwabara H; Evans AC
Acta Radiol Suppl; 1990; 374():117-21. PubMed ID: 1966957
[TBL] [Abstract][Full Text] [Related]
10. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
[TBL] [Abstract][Full Text] [Related]
11. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
[TBL] [Abstract][Full Text] [Related]
12. Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: reduced capillary influx.
Cornford EM; Gee MN; Swartz BE; Mandelkern MA; Blahd WH; Landaw EM; Delgado-Escueta AV
Ann Neurol; 1998 Jun; 43(6):801-8. PubMed ID: 9629850
[TBL] [Abstract][Full Text] [Related]
13. Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans.
Hasselbalch SG; Madsen PL; Knudsen GM; Holm S; Paulson OB
J Cereb Blood Flow Metab; 1998 Feb; 18(2):154-60. PubMed ID: 9469157
[TBL] [Abstract][Full Text] [Related]
14. [Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Enomoto K; Fukunaga T; Okazumi S; Asano T; Kikuchi T; Yamamoto H; Nagashima T; Isono K; Itoh H; Imazeki K
Kaku Igaku; 1991 Nov; 28(11):1353-6. PubMed ID: 1663176
[TBL] [Abstract][Full Text] [Related]
15. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
[TBL] [Abstract][Full Text] [Related]
16. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
17. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
18. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Torizuka T; Tamaki N; Inokuma T; Magata Y; Sasayama S; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the [18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia.
Marshall RC; Huang SC; Nash WW; Phelps ME
J Nucl Med; 1983 Nov; 24(11):1060-4. PubMed ID: 6631527
[TBL] [Abstract][Full Text] [Related]
20. A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
Wu HM; Huang SC; Choi Y; Hoh CK; Hawkins RA
J Nucl Med; 1995 Feb; 36(2):297-306. PubMed ID: 7830134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
